SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
11860412
Source:
http://linkedlifedata.com/resource/pubmed/id/11860412
Search
Subject
(
62
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0003232
,
umls-concept:C0079488
,
umls-concept:C0087111
,
umls-concept:C0205174
,
umls-concept:C0205210
,
umls-concept:C0205225
,
umls-concept:C0683598
pubmed:issue
2
pubmed:dateCreated
2002-2-25
pubmed:abstractText
To evaluate Helicobacter pylori primary resistance and its clinical impact on the efficacy of two lansoprazole-based eradication triple therapies.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8707234
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/2-Pyridinylmethylsulfinylbenzimidazo...
,
http://linkedlifedata.com/resource/pubmed/chemical/Amoxicillin
,
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Bacterial Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Clarithromycin
,
http://linkedlifedata.com/resource/pubmed/chemical/Metronidazole
,
http://linkedlifedata.com/resource/pubmed/chemical/Omeprazole
,
http://linkedlifedata.com/resource/pubmed/chemical/lansoprazole
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0269-2813
pubmed:author
pubmed-author:ChangC SCS
,
pubmed-author:ChenG HGH
,
pubmed-author:LaiC HCH
,
pubmed-author:PoonS KSK
,
pubmed-author:RauW WWW
,
pubmed-author:WangW CWC
,
pubmed-author:YangC CCC
pubmed:issnType
Print
pubmed:volume
16
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
291-6
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:11860412-2-Pyridinylmethylsulfinylbenzimidazoles
,
pubmed-meshheading:11860412-Adult
,
pubmed-meshheading:11860412-Aged
,
pubmed-meshheading:11860412-Aged, 80 and over
,
pubmed-meshheading:11860412-Amoxicillin
,
pubmed-meshheading:11860412-Anti-Bacterial Agents
,
pubmed-meshheading:11860412-Clarithromycin
,
pubmed-meshheading:11860412-Drug Resistance
,
pubmed-meshheading:11860412-Drug Therapy, Combination
,
pubmed-meshheading:11860412-Female
,
pubmed-meshheading:11860412-Helicobacter Infections
,
pubmed-meshheading:11860412-Helicobacter pylori
,
pubmed-meshheading:11860412-Humans
,
pubmed-meshheading:11860412-Male
,
pubmed-meshheading:11860412-Metronidazole
,
pubmed-meshheading:11860412-Middle Aged
,
pubmed-meshheading:11860412-Omeprazole
,
pubmed-meshheading:11860412-Taiwan
pubmed:year
2002
pubmed:articleTitle
Primary resistance to antibiotics and its clinical impact on the efficacy of Helicobacter pylori lansoprazole-based triple therapies.
pubmed:affiliation
Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't